Skip to content
QurAlisQurAlis
  • About UsExpand
    • About QurAlis
    • Leadership
    • Board of Directors
    • Advisors
    • Partners & Investors
    • Contact Us
  • PlatformsExpand
    • QR43 Platform™
    • FlexASO™ Platform
  • Pipeline
  • PatientsExpand
    • ALS Patients
    • A Message of Hope
  • NewsExpand
    • Press Releases
    • Presentations and Publications
  • Careers
QurAlisQurAlis

Presentations and Publications

Home
News
Presentations and Publications

Corporate Presentation

Pioneering Next-Gen Precision Medicine Approaches in ALS and Other Neurodegenerative Diseases

Scientific Presentations and Publications

AD/PD™ 2022, Alzheimer’s and Parkinson’s Diseases Conference

The Impacts of TDP-43 Loss on STATHMIN-2 Expression, Golgi Apparatus Morphology, and Neurite Outgrowth, in Human Cortical and Motor Neurons

https://quralis.com/wp-content/uploads/2022/03/ADPD2022-TDP43-Loss-on-STMN2-Expression-et-al.mp3

Biomarkers for Patient Stratification and Target Engagement in Patients with TDP-43 Pathology

https://quralis.com/wp-content/uploads/2022/03/ADPD2022-Biomarkers-TDP43-Pathology.mp3

32nd International Symposium on ALS/MND
The Time Course and Impacts of TDP-43 Loss on STATHMIN-2 Gene Expression, Protein Abundance, Golgi Apparatus Morphology, Neurite Outgrowth, and Response to Proteotoxic Stress in Human Induced Pluripotent Derived Motor Neurons
Biomarkers for Patient Stratification and Target Engagement in ALS Patients with TDP-43 Pathology
Rapid Generation of Motor Neurons Using Modified Ngn2 Induced iPSC’s to Study ALS Disease
Shipment of Transduced Live iPSC-derived Motor Neurons

100 Cambridgepark Drive, 5th Floor
Cambridge, MA 02140, USA
781-816-7031
info@quralis.com

Twitter Linkedin
  • About Us
  • Platforms
  • Pipeline
  • Patients
  • News
  • Careers
Menu
  • About Us
  • Platforms
  • Pipeline
  • Patients
  • News
  • Careers
© 2021 QurAlis Corporation | Privacy Policy | Terms of Use
  • About Us
    • About QurAlis
    • Leadership
    • Board of Directors
    • Advisors
    • Partners & Investors
    • Contact Us
  • Platforms
    • QR43 Platform™
    • FlexASO™ Platform
  • Pipeline
  • Patients
    • ALS Patients
    • A Message of Hope
  • News
    • Press Releases
    • Presentations and Publications
  • Careers